These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38657250)

  • 1. Buprenorphine Dispensing after Elimination of the Waiver Requirement.
    Chua KP; Bicket MC; Bohnert ASB; Conti RM; Lagisetty P; Nguyen TD
    N Engl J Med; 2024 Apr; 390(16):1530-1532. PubMed ID: 38657250
    [No Abstract]   [Full Text] [Related]  

  • 2. Buprenorphine dispensing before and after the April 2021 X-Waiver exemptions: An interrupted time series analysis.
    Roy PJ; Suda K; Luo J; Lee M; Anderton J; Olejniczak D; Liebschutz JM
    Int J Drug Policy; 2024 Apr; 126():104381. PubMed ID: 38457960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why 24 State and Territorial Health Officials Support Buprenorphine Deregulation.
    Stancliff S; Greene D; Zucker HA
    Am J Public Health; 2019 Dec; 109(12):1678-1679. PubMed ID: 31693402
    [No Abstract]   [Full Text] [Related]  

  • 4. Trends in Buprenorphine Treatment in the United States, 2009-2018.
    Olfson M; Zhang VS; Schoenbaum M; King M
    JAMA; 2020 Jan; 323(3):276-277. PubMed ID: 31961408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using buprenorphine to treat patients with opioid use disorder.
    Radi JK; Fogarty KJ; Lagerwey MD
    JAAPA; 2019 Oct; 32(10):30-35. PubMed ID: 31513035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Datapoints: regional variation in benzodiazepine prescribing for patients on opioid agonist therapy.
    Park TW; Bohnert AS; Austin KL; Saitz R; Pizer SD
    Psychiatr Serv; 2014 Jan; 65(1):4. PubMed ID: 24382761
    [No Abstract]   [Full Text] [Related]  

  • 7. Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US.
    Stein BD; Saloner B; Schuler MS; Gurvey J; Sorbero M; Gordon AJ
    JAMA; 2021 Jun; 325(21):2206-2208. PubMed ID: 34061152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. US ED Opioid-Related Visits Increase, While Use of Medication for Opioid Use Disorder Undetectable, 2011-2016.
    Shastry S; Manini AF; Richardson LD; Lin MP
    J Gen Intern Med; 2020 Mar; 35(3):965-966. PubMed ID: 31414352
    [No Abstract]   [Full Text] [Related]  

  • 9. Buprenorphine prescribing by APRNs.
    Rundio A
    J Addict Nurs; 2012 Feb; 23(1):80-1. PubMed ID: 22468666
    [No Abstract]   [Full Text] [Related]  

  • 10. Buprenorphine Supply, Access, and Quality: Where We Have Come and the Path Forward.
    Breen CT; Fiellin DA
    J Law Med Ethics; 2018 Jun; 46(2):272-278. PubMed ID: 30147002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Did the 2021 federal change in the practice guidelines for the administration of buprenorphine for treating opioid use disorder increase buprenorphine prescription dispensing in Medicaid population?
    Qian J; Khatiwada AP; Xue X
    Am J Addict; 2024 May; 33(3):335-338. PubMed ID: 38069608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11.
    Dick AW; Pacula RL; Gordon AJ; Sorbero M; Burns RM; Leslie D; Stein BD
    Health Aff (Millwood); 2015 Jun; 34(6):1028-34. PubMed ID: 26056209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoption of the 275-patient buprenorphine treatment waiver for treating opioid use disorder: A state-level longitudinal analysis.
    Knudsen HK; Lin LA; Lofwall MR
    Subst Abus; 2020; 41(2):259-268. PubMed ID: 31295057
    [No Abstract]   [Full Text] [Related]  

  • 14. The prescribing of buprenorphine by advanced practice addictions nurses.
    Strobbe S; Hobbins D
    J Addict Nurs; 2012 Feb; 23(1):82-3. PubMed ID: 22468667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increases in Providers With Buprenorphine Waivers in the United States From 2016 to 2019.
    Ghertner R; Ali MM
    Psychiatr Serv; 2020 Sep; 71(9):971. PubMed ID: 32460681
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
    Jones CM; McCance-Katz EF
    Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Outpatient Buprenorphine Dispensing During the COVID-19 Pandemic.
    Cance JD; Doyle E
    JAMA; 2020 Dec; 324(23):2442-2444. PubMed ID: 33320215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of NPs in medication-assisted treatment for opioid use disorder.
    Cotton BP; Ferszt GG
    Nurse Pract; 2018 May; 43(5):8. PubMed ID: 29668514
    [No Abstract]   [Full Text] [Related]  

  • 19. The Number Needed to Prescribe - What Would It Take to Expand Access to Buprenorphine?
    Poorman E
    N Engl J Med; 2021 May; 384(19):1783-1784. PubMed ID: 33983689
    [No Abstract]   [Full Text] [Related]  

  • 20. The disparate treatment of medications and opiate pain medications under the law: permitting the proliferation of opiates and limiting access to treatment.
    Ferrara MM
    Seton Hall Law Rev; 2012; 42(2):741-67. PubMed ID: 22708140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.